IRONWOOD PHARMACEUTICALS INC

By person

17 insiders · 0 transactions

9.8×

Thomas McCourt holds 9.8 times base salary in stock. $8.58M of shares against $867.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas McCourt last reported holding, valued at $4.52, the price Class A Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

DENNER ALEXANDER J

Director

—

9,512,490

$43.00M

−40.8%

MCCOURT Thomas A

Chief Executive Officer

—

1,898,838

$8.58M

+64.8%

Shetzline Michael

SVP, CMO, Head-Res&Drug

—

1,179,462

$5.33M

+30.9%

Silver Ronald

PFO & PAO

—

755,250

$3.41M

+18.9%

Currie Mark G

Director

—

676,900

$3.06M

+19.1%

John Minardo

Chief Legal Officer

—

500,498

$2.26M

+75.8%

Gaskins Tammi L

Chief Commercial Officer

—

350,350

$1.58M

+42.9%

Emany Sravan Kumar

SVP, COO and CFO

—

309,572

$1.40M

−3.4%

Martini Gregory S.

Chief Financial Officer

—

297,213

$1.34M

+250.7%

Davis Andrew

SVP, Chief Business Officer

—

284,685

$1.29M

−1.8%

Duane Jon R

Director

—

253,820

$1.15M

+74.6%

McHugh Julie

Director

—

250,749

$1.13M

+53.0%

Shepard Jay

Director

—

235,036

$1.06M

+85.7%

Kessler Marla L

Director

—

229,364

$1.04M

+89.7%

Dreyfus Andrew

Director

—

228,313

$1.03M

+24.5%

Moukheibir Catherine

Director

—

181,425

$820.04K

+148.7%

Silber Jeffrey

SVP, CMO, Head-Res&Drug

—

137,036

$619.40K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

IRONWOOD PHARMACEUTICALS INC

By person

Individual transactions

What was left out